SRAD Investors Have Opportunity to Lead Sportradar Group AG Securities Fraud Lawsuit

WGS Investors Have Opportunity to Lead GeneDx Holdings Corp. Securities Fraud Lawsuit

Philippine Airlines to Join oneworld Alliance

Ramtech VP of Business Development Kelly Williams to Speak on Modular Construction Benefits in Panel Discussion at 2026 InterFace Houston Multifamily Conference

University of Phoenix researchers publish study examining doctoral students' attitudes toward AI chatbots and ChatGPT use in higher education

Bybit EU posiluje své postavení v Evropě před přechodem na regulaci MiCAR

82% of Adults with Type 2 Diabetes Not on Insulin Improve Blood Glucose Levels with Continuous Glucose Monitoring

Breakthrough Studies Demonstrate Effectiveness of the First Triple-Hormone Therapy for Type 2 Diabetes and Obesity

Lilly's triple agonist, retatrutide, drove substantial improvements in weight, A1C, knee osteoarthritis pain, and obstructive sleep apnea, demonstrating its remarkable potential to treat obesity and its complications

Bitmine Immersion Technologies kondigt prijsstelling aan van verhoogde aanbieding van eeuwigdurende preferente aandelen uit Serie A

Bitmine Immersion Technologies gibt die Preisgestaltung für die aufgestockte Emission von unbefristeten Vorzugsaktien der Serie A bekannt

Bitmine Immersion Technologies annonce le prix de son offre élargie d'actions privilégiées perpétuelles de série A

Rosen Law Firm Encourages PennyMac Financial Services, Inc. Investors to Inquire About Securities Class Action Investigation - PFSI

CERAVE NA PRVNÍCH CELOSVĚTOVÝCH CERAWARDS PŘIVÍTALO VÍCE NEŽ 100 OCENĚNÝCH TVŮRCŮ OBSAHU Z 22 ZEMÍ

Novo Nordisk to present new data on Wegovy® across a wide range of cardiometabolic conditions at the American Diabetes Association's 2026 Scientific Sessions

Bybit EU renforce son positionnement européen avant la transition vers le règlement MiCA

TEAMEX Delivers First EV-Drill LANCE in the United States to Pennsylvania Fire Department

MONDAY INVESTOR DEADLINE: Medpace Holdings Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit, Robbins Geller Rudman & Dowd LLP Announces - MEDP

In HelloNation, Periodontics Expert Dr. Scott Kissel of Manhattan, NY, Details Why Microsurgical Techniques Matter in Periodontal Care

MONDAY INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Stellantis N.V. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit - STLA

PureHealth Research Highlights Growing Consumer Interest in Lymphatic Wellness and Botanical Support

Clinical Amino Acid Profiles Anchor PureHealth Research's New Natural Peptides Supplements

Quantinuum annonce la clôture de son premier appel public à l'épargne élargi

Lifeline AI gewinnt das Red Bull Basement World Final, bei dem 100.000 US-Dollar als Finanzierung ohne Abgabe von Unternehmensanteilen vergeben werden

INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Zoetis Inc. (ZTS) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

AVAV INVESTOR NOTICE: AeroVironment, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit, Robbins Geller Rudman & Dowd LLP Announces

Quantinum anuncia el cierre de su oferta pública inicial ampliada

Quantinuum gibt Abschluss des erweiterten Börsengangs bekannt

People with type 2 diabetes who were increased to semaglutide 2 mg were as likely to achieve an HbA1c less than 7% and more likely to achieve greater than 5% weight loss than those who were switched to tirzepatide, in real-world data

New Abbott data show many people with diabetes may not recognize symptoms of diabetic ketoacidosis